Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Mitja Zidar, Blaž Lebar, Nika Strašek, Goran Miličić, Aleš Žula
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Molecular basis of high viscosity in concentrated antibody solutions: Strategies for high concentration drug product development
10.1080/19420862.2015.1128606 · 2016
Intermolecular Interactions and the Viscosity of Highly Concentrated Monoclonal Antibody Solutions
10.1007/s11095-015-1690-6 · 2015
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study
10.1111/bjh.16227 · 2020
Viscosity-Lowering Effect of Amino Acids and Salts on Highly Concentrated Solutions of Two IgG1 Monoclonal Antibodies
10.1021/acs.molpharmaceut.5b00643 · 2015
Contrasting the Influence of Cationic Amino Acids on the Viscosity and Stability of a Highly Concentrated Monoclonal Antibody
10.1007/s11095-016-2055-5 · 2017
High throughput thermostability screening of monoclonal antibody formulations
10.1002/jps.21955 · 2010
Bulky Polar Additives That Greatly Reduce the Viscosity of Concentrated Solutions of Therapeutic Monoclonal Antibodies
10.1016/j.xphs.2017.01.018 · 2017
10.1002/bit.22983
10.1002/bit.22983
Novel salts of dipicolinic acid as viscosity modifiers for high concentration antibody solutions
Confidence 92%
datacite
Confidence 0%
2018
A Formulation Development Approach to Identify and Select Stable Ultra–High-Concentration Monoclonal Antibody Formulations With Reduced Viscosities
10.1016/j.xphs.2017.06.017 · 2017
Structure-Activity Relationship for Hydrophobic Salts as Viscosity-Lowering Excipients for Concentrated Solutions of Monoclonal Antibodies
10.1007/s11095-012-0802-9 · 2012
Evolution of commercially available compounds for HTS
10.1016/j.drudis.2018.10.016 · 2019
Characterization of 30 therapeutic antibodies and related products by size exclusion chromatography: Feasibility assessment for future mass spectrometry hyphenation
10.1016/j.jchromb.2017.09.027 · 2017
10.1073/pnas.0904191106
10.1073/pnas.0904191106
Determination of isoelectric points and relative charge variants of 23 therapeutic monoclonal antibodies
10.1016/j.jchromb.2017.09.033 · 2017
Computational tool for the early screening of monoclonal antibodies for their viscosities
10.1080/19420862.2015.1099773 · 2016
10.1016/j.addr.2011.08.003
10.1016/j.addr.2011.08.003
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
10.1007/978-3-540-78246-9_38
10.1007/978-3-540-78246-9_38
PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS
10.1021/jm5019093 · 2015
10.1002/cmdc.200700139
10.1002/cmdc.200700139
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
10.1021/acs.jcim.0c00675
10.1021/acs.jcim.0c00675
Unresolved referenced work
Kept as external metadata until matched
10.1186/1758-2946-3-33
10.1186/1758-2946-3-33
Unresolved referenced work
Kept as external metadata until matched
Epik: a software program for pKaprediction and protonation state generation for drug-like molecules
10.1007/s10822-007-9133-z · 2007
In Silico Tools for Sharing Data and Knowledge on Toxicity and Metabolism: Derek for Windows, Meteor, and Vitic
10.1080/15376510701857320 · 2008
Polar Solvents Decrease the Viscosity of High Concentration IgG1 Solutions Through Hydrophobic Solvation and Interaction: Formulation and Biocompatibility Considerations
10.1002/jps.23453 · doi-reference
10.1039/9781849733045
10.1039/9781849733045 · doi-reference
Self-Buffering Antibody Formulations
10.1002/jps.21232 · doi-reference
10.1016/j.jcis.2020.06.105
10.1016/j.jcis.2020.06.105 · doi-reference
Development of high concentration protein biopharmaceuticals: The use of platform approaches in formulation development
10.1016/j.ejpb.2011.03.004 · doi-reference
Long- and Short-Range Electrostatic Interactions Affect the Rheology of Highly Concentrated Antibody Solutions
10.1007/s11095-009-9975-2 · doi-reference
ADME Evaluation in Drug Discovery. 2. Prediction of Partition Coefficient by Atom-Additive Approach Based on Atom-Weighted Solvent Accessible Surface Areas
10.1021/ci034007m · doi-reference
10.1016/s0169-409x(96)00423-1
10.1016/s0169-409x(96)00423-1 · doi-reference
Molecular Similarity in Medicinal Chemistry
10.1021/jm401411z · doi-reference